Author: Monica Abel

Three Ways to Beat Vaccine Hesitancy and Boost Your Community Health

As your pharmacy and patients jump headfirst into the school year and fast forward into flu season, it’s a good time to recover from the ongoing controversy surrounding vaccinations and refocus on their benefits to the community. To read more: KPPA_3

Breaking Down Three Critical Patient Connection Barriers – Part 2

Communication, beyond simply great services, is likely the top way for an independent pharmacy to bust through patient connection barriers. But beyond going back to grad school to master health literacy, what are key methods we can use to ensure

First Rate Patient Care Part 1: 3 Steps to Breaking Barriers

While drug makers are working to develop medications and make them more marketable, physicians and providers are doing double-duty ensuring patients receive the medications and therapies best suited for their individual needs. And these events open opportunities for community pharmacies.

Current News Coverage Summary

Your PA Community Pharmacies_Sept Your PA Community Pharmacies is a coalition of your independent pharmacies across Pennsylvania, who take pride in being long-standing members of the community.  Check out the above link for current news articles across Pennsylvania counties.

USP <800> Assessment of Risk Templates Available Now

NCPA has developed a blank USP <800> risk assessment template, and a sample template for testosterone, to help you create your own risk assessments for each hazardous drug as required by USP <800>. USP General Chapter <800>’s implementation date is

USP <800> Regulations

Effective 12/1/2019, the following procedures for handling Hazardous Drugs must be complied with: Here is the latest list (May 2019) of Hazardous Drugs from NIOSH – Lists drugs such as Dilantin, Klonopin, Coumadin, & Depakote so please review carefully. These

Financial Challenges and Your Pharmacy: How to Take on the Giants

Out of all the challenges thrown at independent pharmacies today, those most likely to keep you awake at night are financial – especially as you continue to take on retail giants. In fact, these challenges are so pressing, they continue

How to ‘Not’ Make Your Pharmacy Obsolete – Embracing New Care Models May Help Boost Your Pharmacy’s Future Health

Some researchers say that pharmaceuticals have grown to consume up to 30 percent of each healthcare dollar. With that in mind, your community pharmacy may need to rethink traditional care models to drive improved outcomes and value – or risk

4 Trends That Can Make, Shake, or Break Your Pharmacy

Keystone_Blog_4 Trends that Make or Break Pharmacy

Mass Action Lawsuit Against Optum Rx is Progressing

Purpose: – Expose unfair PBM practices in reimbursements, such as MAC Payments, price discrimination compared to amounts paid to mail order and mega-chains. – Focus attention on a single, large PBM – Minimize individual pharmacies legal costs by using the

The 80/20 Rule: Can Your Pharmacy Make More Money With Less?

Keystone_Blog_80 20 Rule Make More_062119

Building Adherence Into Your Pharmacy

Keystone_Blog_Building Adherence into Your Pharmacy

NCPA 2019 Annual Convention

NCPA 2019 Annual Convention. Special Code for Keystone Members, save $100 using code Buy100. This rate is for owner/managers and staff pharmacists ONLY. Don’t miss out on this amazing rate and all that Convention has to offer. Mark your calendar


Learn how to prepare your business and to navigate the reimbursement process for annual flu vaccines. We are excited to invite you and your members to participate in an upcoming webinar on the topic of payer reimbursement for influenza vaccines

Resources to Support DIR Aspects of Proposed Drug Pricing Rule

NCPA has created sample comments that you can easily and quickly submit through our grassroots portal. It is vital that as many comments as possible are submitted prior to the Jan. 25 deadline to compel the administration to finalize their

Pharmacists are getting squeezed by 2 of the world’s biggest companies. Here’s how they’re fighting back.

Independent pharmacists have been facing a changing industry for decades but have managed to maintain a presence in communities around the US. As reimbursements dwindle, pharmacists are starting to get creative, looking for new ways to get paid by health

Abbott’s FreeStyle Libre System Now Available to Independents

Independent pharmacists now can order the Abbott FreeStyle Libre 14-day system from their wholesaler. This pharmacy resource guide contains product information and wholesaler order numbers for both the FreeStyle Libre 14-day Reader and FreeStyle Libre 14-day Sensor. Since its introduction,

Statement From FDA Commissioner Scott Gottlieb, M.D., on Proposed New Steps to Protect Youth by Preventing Access to Flavored Tobacco Products and Banning Menthol in Cigarettes

Philly May Require All Pharmacies to Stock Overdose-reversal Drug Naloxone  

Express Scripts Launches a New Formulary for a World Without Rebates. Will Plan Sponsors and Drug Makers Play Along?

NCPA Advocacy Successes and How Those Are Helping Advance Our Effort to Eliminate Pharmacy DIR

Why haven’t the Chains been joining us in complaining to the world about reimbursement pricing?

Attached is a flyer showing how Independents are being paid compared to the major chains…. All I can say is WOW! Show this to your PSAO – can they explain the difference in reimbursement? On this one Rx for Quetiapine

Department of Justice Approval of Mergers and How They Will Affect Independents

As you have already heard the Department of Justice has approved both the CVS/Aetna & Cigna/ESI mergers. A few members have already called me to VENT – now I would like you all to VENT to the proper people within

Delaware County Hearing With The Auditor General

The Auditor General, Eugene DePasquale, held his second hearing on the questionable business practices of PBMs in Delaware County on September 12, 2018 The Auditor General in his press conference stated he “is committed to looking into the PBM practices,

Pharmacy Owners: A New Alternative to Keeping Independent Pharmacy Independent

Do Prescription Drug Middlemen Help Keep Prices High?

Auditor General DePasquale Initiates Review to Bring Transparency, Accountability to Prescription Drug Pricing

HARRISBURG (June 13, 2018) – Auditor General Eugene DePasquale today said he is launching a review to bring transparency and accountability to prescription drug pricing in Pennsylvania. The result will be a special report focused on practices by pharmacy benefit managers (PBMs),

 Pharmacist Continuing Education Requirements

  To renew their pharmacist licenses, pharmacists are required to complete pharmacist continuing education approved by the Accreditation Council for Pharmacy Education (ACPE) or by the Pennsylvania State Board of Pharmacy (Board).  Of the total 30 contact hours that pharmacists

Pharmacists Gag Rule

PARD’s Mel Brodsky has something to say about the gag rule:

NCPA Advocacy Center Update – Week Ending May 4, 2018

NCPA Urges CMS to Pursue Rulemaking Addressing Retroactive DIR Fees This week, NCPA sent a letter (see attached) to CMS urging the agency to move forward with proper rulemaking to require pharmacy DIRs to be accounted for at point-of-sale. The

NCPA Advocacy Center Update – Week Ending April 27, 2018

NCPA Efforts Result in Key Pharmacy Protections in Senate and House Opioid Bills This week, both chambers of Congress took the first steps in advancing legislation to address the opioid crisis. The Senate Health, Education, Labor, and Pensions (HELP) Committee

Consumer Confidential: They’re called ‘co-pay accumulators,’ and they’re a way insurers make you pay more for meds

Mary Hawley takes the widely used drug Humira for her rheumatoid arthritis. It can cost tens of thousands of dollars a year, but for nearly a decade Hawley has been assisted with discount coupons from the drug’s manufacturer, AbbVie.  “You

FDA Drug Safety Communication: FDA warns of serious immune system reaction with seizure and mental health medicine lamotrigine (Lamictal)

The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body’s infection-fighting immune system. This can cause severe inflammation throughout

Webinar on Prescription Drugs and Heroin

WEBINAR – REGISTER NOW PRESCRIPTION DRUGS AND HEROIN Thursday, April 26, 2018 2:00 p.m. to 3:00 p.m. ET I 1:00 p.m. to 2:00 p.m. CT The opioid epidemic is having an ongoing serious impact on communities throughout the United States.

How will the new tax laws affect your business?

Are you up on how the new tax law will affect small business like yours? Sign up for this webinar by Ollin Sykes, CPA with Sykes & Co., to make sure you’re up to date. This webinar will help you

NCPA Advocacy Center Update – Week Ending April 20, 2018

NCPA Introduces MedPAC Nominee to Key Hill Staff This week NCPA government affairs staff accompanied NCPA’s Medicare Payment Advisory Commission (MedPAC) nominee Troy Trygstad to meetings with staff from key Congressional committees that have jurisdiction over Medicare. These included discussions

NCPA Advocacy Center Update – Week Ending April 6, 2018

NCPA Congressional Pharmacy Summit Only Days Away The NCPA Congressional Pharmacy Summit is days away. Registration is available onsite for anyone who has not yet registered but still wants to take advantage of several CE opportunities as we provide you

Special NCPA Advocacy Center Update- CMS Issues Final 2019 Medicare Part D Rule and Call Letter

On April 2, 2018 The Centers for Medicare & Medicaid Services released their final Part D Rule and final Call Letter for 2019 Medicare Part D and Medicare Advantage plans. NCPA is conducting a thorough analysis of each and will

Advocates Urge Congress to Include Provider Status Bill

NACDS RxIMPACT launched an all-out letter-writing campaign the week of March 26, urging pharmacy advocates to spotlight the value of H.R. 592, The Pharmacy and Medically Underserved Areas Enforcement Act. Advocates should ask their representatives to include the legislation in

NCPA Advocacy Center Update – Week Ending March 30, 2018

Online Registration Deadline Fast Approaching for NCPA Congressional Pharmacy Summit The deadline to register online for the NCPA Congressional Pharmacy Summit is Wednesday April 4.  Any registrations after that date must be done on site. Don’t miss the opportunity to

Unfair Pharmacy Reimbursement

Please see the attached memo. PA House of Representatives Memo-Unfair Reimbursement and PBM Gag

NCPA Advocacy Center Update – Week Ending March 16, 2018

Only Hours Remain to Obtain Group Rate for Congressional Pharmacy Summit Hotel The deadline to reserve your room at NCPA’s group rate for the Congressional Pharmacy Summit is midnight tonight. If you have not registered and made your hotel reservation,

NCPA Advocacy Center Update – Week Ending March 9, 2018

Cigna Seeks to Acquire Express Scripts; NCPA Expresses Concerns This week Cigna announced its intention to purchase Express Scripts. This announcement continues the consolidation trend in the health care marketplace and comes as regulators continue to examine the impacts on

Health Insurer Cigna to Buy Express Scripts in $67 Billion Deal

U.S. health insurer Cigna said on Thursday it would buy pharmacy benefits manager Express Scripts for about $54 billion, the latest deal in the sector aimed at tackling soaring healthcare costs. The move follows the $69 billion merger of insurer Aetna and drugstore chain CVS Health announced last

Allergan Attempt to Move Restasis Patent to Saint Regis Mohawk Tribe Did Not Work

After months of criticism that even spilled into a judge’s opinion in a separate case, Allergan’s Restasis patent deal with the Saint Regis Mohawk Tribe just didn’t work. Thanks to a Friday ruling, the blockbuster eye drug has to face

NCPA Advocacy Center Update – Week Ending February 23, 2018

NCPA member Richard Logan to testify before Congress next week: The House Energy & Commerce Subcommittee on Health has scheduled a hearing on the opioid crisis entitled “Combating the Opioid Crisis: Helping Communities Balance Enforcement and Patient Safety” at 1

Pharmacy Reimbursement

Please watch this legislative video on pharmacy reimbursement.  

NCPA Advocacy Center Update – Week Ending February 16, 2018

PBM industry concentration questioned as Senate, House review health care industry: At a House Energy and Commerce Subcommittee on Oversight and Investigations hearing on concentration in the health care system, concerns raised by NCPA about the PBM marketplace was one

Register for Pharmacy Legislative Day

The Pennsylvania Pharmacists Association is hosting its annual Pharmacy Legislative Day in Harrisburg, PA on Monday, April 16, 2018. Attend and talk with Pennsylvania legislators about the issues that affect you and the patients you serve. Help us advocate for

NCPA Advocacy Center Update – Week Ending February 9, 2018

Trump Administration budget proposal to address prescription drug prices: In advance of the Feb. 12 release of the President’s FY 2019 budget proposal, aides previewed a range of proposals intended to address prescription drug prices. The White House Council of